Sign in

CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474272481
Phone
650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale General Counsel & Corp. Sec'y sold 4,755 shares at $17.55 ($83,450)
  2. 4 Planned sale General Counsel & Corp. Sec'y sold 12,778 shares at $18.01 ($230,120)
  3. 4 Planned sale Chief Medical Officer sold 22,321 shares at $18.01 ($401,981)
  4. 4 Planned sale Chief Business Officer sold 17,937 shares at $18.01 ($323,029)
  5. 4 Planned sale Chief Financial Officer sold 19,771 shares at $18.01 ($356,058)
  6. 4 Planned sale President and CEO sold 70,150 shares at $18.01 ($1,263,338)
  7. 4 Grant or award General Counsel & Corp. Sec'y acquired 27,187 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 43,750 shares (grant or award)
  9. 4 Grant or award Chief Business Officer acquired 35,156 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 38,750 shares (grant or award)
  11. 4 Grant or award President and CEO acquired 137,500 shares (grant or award)
  12. 4 Option exercise Chief Financial Officer acquired 30,750 shares (option exercise)
  13. 4 Option exercise Chief Financial Officer acquired 5,800 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 11 · 215 filings